Healthcare Industry News: cryoprobe
News Release - September 15, 2006
Arbel Medical Unveils Innovative APOC(TM) Cryosurgical Technology
Developer of Next-Generation Cryosurgical Solutions to Present Affordable, Office-Oriented, Adjustable Cryogen Pulse Solutions at Medtech InSight In3 Europe 2006 ConferenceYOKNEAM, Israel--(HSMN NewsFeed)--Sept. 15, 2006--Arbel Medical Ltd., a developer of advanced medical devices focused on minimally invasive technologies for tissue and tumor ablation, today announced it will be presenting its innovative APOC(TM) technology at Medtech Insight's "Investment in Innovation (In3) Europe: A Preview of Early-Stage Medical Technology Companies" conference, to be held September 18-20, 2006, at the Crowne Plaza Brussels City Centre Hotel in Brussels, Belgium.
APOC, which stands for Adjustable Pulses of Cryogen, represents a significant step forward in the field of cryosurgery. The technology facilitates the development of affordable systems enabling cryoprobe or flexible cryocatheter with high freezing capacity and low operating pressure. Arbel Medical's first APOC-based platform, which enables general cryosurgery procedures to be performed in a low-cost, patient-friendly office setting, places preliminary focus on breast care and dermatology applications and will be available for clinical testing in early 2007.
"APOC is a breakthrough technological platform representing the third generation of cryosurgical systems," explained Didier Toubia, Arbel Medical's Chief Executive Officer. "It is a highly effective alternative to current standard lumpectomy or partial mastectomy treatments, which require the use of operating rooms and involve sedation, scarring, and 2 to 3 days of post-op recovery." Toubia added: "Arbel Medical plans to leverage its patented APOC core technology to address an ever-growing range of medical applications in office-based environments. Our vision is to reduce health care costs by as much as 40-50%, while improving patient care and compliance in comparison to existing treatment options."
About Arbel Medical Ltd.
Arbel Medical is a private, VC-backed developer of innovative, minimally invasive cryotherapy and cryosurgery ablation devices, with a preliminary focus on benign tumor and tissue ablation. The company's office-oriented devices are based on unique cryosurgery technology, which offers such benefits as safe and reliable treatment and reduction of surgical and hospitalization costs. For more information, please visit www.arbel-medical.com.
About Medtech Insight's Investment in Innovation (In3) Europe Conference
Medtech Insight's In3 conference highlights emerging technologies developed by more than 50 innovative start-up medical technology companies -- from both Europe and the U.S. -- seeking strategic partners and/or investment. The conference is attended by hundreds of senior-level decision-makers from the investment community and from major medical technology, biopharmaceutical, biotech, and other companies.
Source: Arbel Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
